The invention relates a compound represented by the formula (1):
Q
1
-Q
2
-C(═O)—N(R
1
)-Q
3
-N(R
2
)-T
1
-Q
4
(
1
)
wherein R
1
and R
2
represent H or the like; Q
1
represents an aromatic ring, heterocyclic ring or the like; Q
2
represents a single bond, aromatic ring, heterocyclic ring or the like; Q
3
represents a group
1
or the like, Q
4
represents an aromatic ring, heterocyclic ring or the like; and T
1
represents —CO— or —SO
2
—, and a medicine which comprises the compound and is useful for thrombosis and embolism.
Fluorescent dye compounds, conjugates and uses thereof
申请人:Life Technologies Corporation
公开号:EP2371927A1
公开(公告)日:2011-10-05
The present teachings generally relate to fluorescent dyes, linkable forms of fluorescent dyes, energy transfer dyes, reagents labeled with fluorescent dyes and uses thereof.
本教导一般涉及荧光染料、荧光染料的可连接形式、能量转移染料、用荧光染料标记的试剂及其用途。
Monoacylated 1,2-diaminocycloalkanes
申请人:DAIICHI PHARMACEUTICAL CO., LTD.
公开号:EP2431370A1
公开(公告)日:2012-03-21
Compounds represented by the following general formula (9):
The compounds (9) are synthetic intermediates of pharmacologically active products.
以下通式(9)所代表的化合物:
化合物(9)是药理活性产品的合成中间体。
ETHYLENEDIAMINE DERIVATIVES
申请人:Daiichi Sankyo Company, Limited
公开号:EP1270557B1
公开(公告)日:2012-07-25
402. Aminohydroxynaphthoic acids. Part I. Synthesis of 6-amino-4-hydroxy-2-naphthoic acid (“carboxy γ-acid”)